Development of a 90‐Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection

[1]  Y. Lotan,et al.  Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study , 2017, The Journal of urology.

[2]  John D Seigne,et al.  Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. , 2016, The Journal of urology.

[3]  Y. Lotan,et al.  Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer. , 2016, The Urologic clinics of North America.

[4]  J. Witjes,et al.  Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study. , 2016, European journal of cancer.

[5]  A. Pendergast,et al.  The Emerging Role of ABL Kinases in Solid Tumors. , 2015, Trends in cancer.

[6]  Andreas Böhle,et al.  Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS) , 2014 .

[7]  Y. Jeng,et al.  Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system , 2013, Histopathology.

[8]  M. Dalphin,et al.  A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria. , 2012, The Journal of urology.

[9]  M. Burset,et al.  Gene Expression Signature in Urine for Diagnosing and Assessing Aggressiveness of Bladder Urothelial Carcinoma , 2010, Clinical Cancer Research.

[10]  J. Witjes,et al.  Recurrence, Progression, and Follow-Up in Non–Muscle-Invasive Bladder Cancer , 2009 .

[11]  J. Fitzpatrick,et al.  Urinary insulin‐like growth factor 2 identifies the presence of urothelial carcinoma of the bladder , 2009, BJU international.

[12]  T. Kwast,et al.  Urine markers for bladder cancer surveillance: a systematic review. , 2005 .

[13]  William A. Mcmillan,et al.  Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. , 2005, Clinical chemistry.

[14]  D. Polsky,et al.  Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients , 2004, International journal of cancer.

[15]  J. Southgate,et al.  Human uroplakin lb gene structure and promoter analysis. , 2002, Biochimica et biophysica acta.

[16]  T. Tammela,et al.  Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. , 2002, European urology.

[17]  T. Sano,et al.  Expression of corticotropin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  S. Wilczynski,et al.  Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors , 1998, Cell and Tissue Research.

[19]  Russell Higuchi,et al.  Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions , 1993, Bio/Technology.